# Evolus, Inc.: filings

EOLS · Nasdaq · CIK 1570562 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eols.md) · [Financials](/companies/eols/financials.md) · [Filings](/companies/eols/filings.md) · [Insiders](/companies/eols/insiders.md)

## Reports and events: 153 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 224, 8-K 99, 10-Q 26, 3 23, SC 13G/A 19, SC 13G 15, CORRESP 14, UPLOAD 13, 144 12, S-8 12, SCHEDULE 13G/A 12, 10-K 9, DEF 14A 8, DEFA14A 8, 424B5 7, 4/A 5, EFFECT 5, 424B4 4, ARS 4, SCHEDULE 13G 4, S-1/A 3, S-3 3, S-3/A 3, SC 13D/A 3, D 2, DRS 2, DRS/A 2, DRSLTR 2, S-1 2, 10-K/A 1, 10-Q/A 1, 8-A12B 1, CERT 1, CT ORDER 1, FWP 1, PRE 14A 1, S-3MEF 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 16:56 ET | [10-Q](/filings/0001628280-26-053468.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053468 |
| 2026-08-05 | 16:17 ET | [8-K](/filings/0001628280-26-053384.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053384 |
| 2026-08-04 | 08:46 ET | [8-K](/filings/0001570562-26-000083.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001570562-26-000083 |
| 2026-07-08 | 09:03 ET | [8-K](/filings/0001570562-26-000079.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001570562-26-000079 |
| 2026-06-12 | 16:19 ET | [8-K](/filings/0001570562-26-000076.md) | 5.07 Shareholder vote results | 0001570562-26-000076 |
| 2026-05-04 | 17:00 ET | [10-Q](/filings/0001570562-26-000066.md) | Quarterly report, period 2026-03-31 | 0001570562-26-000066 |
| 2026-05-04 | 16:05 ET | [8-K](/filings/0001570562-26-000064.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001570562-26-000064 |
| 2026-04-29 | 09:28 ET | [DEF 14A](/filings/0001570562-26-000059.md) | Proxy statement, period 2026-06-11 | 0001570562-26-000059 |
| 2026-03-13 | 16:43 ET | [8-K](/filings/0001570562-26-000043.md) | 5.02 Departure or appointment of officers or directors | 0001570562-26-000043 |
| 2026-03-03 | 17:01 ET | [10-K](/filings/0001628280-26-014001.md) | Annual report, period 2025-12-31 | 0001628280-26-014001 |
| 2026-03-03 | 16:25 ET | [8-K](/filings/0001628280-26-013872.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-26-013872 |
| 2026-01-09 | 08:34 ET | [8-K](/filings/0001570562-26-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-26-000003 |
| 2025-11-05 | 17:02 ET | [10-Q](/filings/0001628280-25-049673.md) | Quarterly report, period 2025-09-30 | 0001628280-25-049673 |
| 2025-11-05 | 16:12 ET | [8-K](/filings/0001628280-25-049564.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-049564 |
| 2025-09-08 | 08:32 ET | [8-K](/filings/0001570562-25-000110.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001570562-25-000110 |
| 2025-08-05 | 17:00 ET | [10-Q](/filings/0001570562-25-000098.md) | Quarterly report, period 2025-06-30 | 0001570562-25-000098 |
| 2025-08-05 | 16:06 ET | [8-K](/filings/0001570562-25-000094.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001570562-25-000094 |
| 2025-06-06 | 16:20 ET | [8-K](/filings/0001570562-25-000085.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001570562-25-000085 |
| 2025-05-27 | 16:18 ET | [8-K](/filings/0001570562-25-000083.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001570562-25-000083 |
| 2025-05-07 | 17:02 ET | [10-Q](/filings/0001570562-25-000075.md) | Quarterly report, period 2025-03-31 | 0001570562-25-000075 |
| 2025-05-07 | 16:07 ET | [8-K](/filings/0001570562-25-000074.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-25-000074 |
| 2025-05-05 | 16:08 ET | [8-K](/filings/0001570562-25-000069.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001570562-25-000069 |
| 2025-04-25 | 17:00 ET | [DEF 14A](/filings/0001570562-25-000066.md) | Proxy statement, period 2024-12-31 | 0001570562-25-000066 |
| 2025-03-04 | 16:40 ET | [10-K](/filings/0001570562-25-000020.md) | Annual report, period 2024-12-31 | 0001570562-25-000020 |
| 2025-03-04 | 16:08 ET | [8-K](/filings/0001570562-25-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-25-000017 |
| 2025-01-21 | 08:03 ET | [8-K](/filings/0001570562-25-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-25-000006 |
| 2024-11-06 | 16:37 ET | [10-Q](/filings/0001570562-24-000128.md) | Quarterly report, period 2024-09-30 | 0001570562-24-000128 |
| 2024-11-06 | 16:15 ET | [8-K](/filings/0001570562-24-000127.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-24-000127 |
| 2024-07-31 | 17:00 ET | [10-Q](/filings/0001570562-24-000116.md) | Quarterly report, period 2024-06-30 | 0001570562-24-000116 |
| 2024-07-31 | 16:12 ET | [8-K](/filings/0001570562-24-000114.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-24-000114 |
| 2024-07-01 | 16:39 ET | [8-K](/filings/0001570562-24-000104.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001570562-24-000104 |
| 2024-06-11 | 16:05 ET | [8-K](/filings/0001570562-24-000098.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001570562-24-000098 |
| 2024-05-07 | 17:00 ET | [10-Q](/filings/0001570562-24-000080.md) | Quarterly report, period 2024-03-31 | 0001570562-24-000080 |
| 2024-05-07 | 16:14 ET | [8-K](/filings/0001570562-24-000078.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-24-000078 |
| 2024-04-26 | 16:55 ET | [DEF 14A](/filings/0001570562-24-000072.md) | Proxy statement, period 2023-12-31 | 0001570562-24-000072 |
| 2024-04-03 | 16:29 ET | [8-K](/filings/0001570562-24-000061.md) | 5.02 Departure or appointment of officers or directors | 0001570562-24-000061 |
| 2024-03-13 | 16:59 ET | [8-K](/filings/0001570562-24-000049.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001570562-24-000049 |
| 2024-03-07 | 16:42 ET | [10-K](/filings/0001570562-24-000041.md) | Annual report, period 2023-12-31 | 0001570562-24-000041 |
| 2024-03-07 | 16:09 ET | [8-K](/filings/0001570562-24-000038.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-24-000038 |
| 2024-01-16 | 17:28 ET | [8-K](/filings/0001570562-24-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-24-000003 |
| 2023-12-20 | 08:33 ET | [8-K](/filings/0001570562-23-000119.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001570562-23-000119 |
| 2023-11-07 | 17:13 ET | [10-Q](/filings/0001570562-23-000115.md) | Quarterly report, period 2023-09-30 | 0001570562-23-000115 |
| 2023-11-07 | 16:24 ET | [8-K](/filings/0001570562-23-000114.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-23-000114 |
| 2023-08-14 | 16:05 ET | [SC 13D/A](/filings/0001477932-23-006088.md) | Ownership report, active investor, amended | 0001477932-23-006088 |
| 2023-08-02 | 17:24 ET | [10-Q](/filings/0001570562-23-000088.md) | Quarterly report, period 2023-06-30 | 0001570562-23-000088 |
| 2023-08-02 | 16:08 ET | [8-K](/filings/0001570562-23-000086.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-23-000086 |
| 2023-07-27 | 08:55 ET | [8-K](/filings/0001570562-23-000082.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001570562-23-000082 |
| 2023-06-14 | 16:39 ET | [8-K](/filings/0001570562-23-000079.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001570562-23-000079 |
| 2023-05-09 | 17:12 ET | [10-Q](/filings/0001570562-23-000070.md) | Quarterly report, period 2023-03-31 | 0001570562-23-000070 |
| 2023-05-09 | 16:07 ET | [8-K](/filings/0001570562-23-000068.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001570562-23-000068 |

Page 1 of 4. [Older](/companies/eols/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.